The dispute is expected to reach the US Supreme Court eventually, with the outcome remaining far from clear;  the potential rift between the US Justice Department and Patent and Trademark Office continues. Certainly, the pressure for a change in gene patenting is rising; commentator Dan Vorhaus notes the potential for conflict given the rise of whole genome sequencing technologies and their application for all kinds of personalised medicine.

comments powered by Disqus